Skip to main content
SpringerLink
Log in

Pharmacoepidemiology

  • Chapter
  • First Online:
Communicating about Risks and Safe Use of Medicines

Abstract

Pharmacoepidemiology is the study of the use of medicines in populations and their use as determinants of health. As such pharmacoepidemiological research is also subject to medicinal product risk communication and also provides methods for investigating the impact of communication—whether from official bodies, in the media or in healthcare—on the use of medicines and its health outcomes. The results of such evaluations constitute major evidence for planning and improving product information, communication components of risk minimisation measures and other actions of regulatory bodies and healthcare systems alike. As such pharmacoepidemiology has been called the fundamental science of medicines safety in patient care and is also seen as a corner stone of regulatory science and decision-making. This chapter reviews appropriateness and potential of pharmacoepidemiological research methods for the purpose of medicinal product risk communication research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bakhriansyah M, Souverein PC, de Boer A, Klungel OH (2017) Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control study. Pharmacoepidemiol Drug Saf 26(10):1141–1148

    Article  CAS  Google Scholar 

  • Bergman U (2006) The history of the drug utilization research group in Europe. Pharmacoepidemiol Drug Saf 15(2):95–98

    Article  Google Scholar 

  • Bernal JL, Cummins S, Gasparrini A (2017) Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 46(1):348–355

    PubMed  Google Scholar 

  • Blind E, Dunder K, de Graeff PA, Abadie E (2011) Rosiglitazone: a European regulatory perspective. Diabetologia 54(2):213–218

    Article  CAS  Google Scholar 

  • Boston Collaborative Drug Surveillance Programme (1973) Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Lancet 1(7817):1399–1404

    Google Scholar 

  • Carson JL, Strom BL, Soper KA, West SL, Morse ML (1987) The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med 147(1):85–88

    Article  CAS  Google Scholar 

  • Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R (1989) Prescribed fenoterol and death from asthma in New Zealand, 1981–83: case-control study. Lancet 1(8644):917–922

    Article  CAS  Google Scholar 

  • EMA Assessment report for nimesulide containing medicinal products for systemic use (2012) https://www.ema.europa.eu/en/documents/referral/nimesulide-article-31-referral-assessment-report_en.pdf

  • EMA PRAC recommendations on signals (2018) https://www.ema.europa.eu/en/documents/prac-recommendation/prac-recommendations-signals-adopted-3-6-september-2018-prac-meeting_en-0.pdf

  • Evans SJ (2012) Pharmacoepidemiology. Br J Clin Pharmacol 73(6):973–978

    Article  Google Scholar 

  • Feltelius N, Persson I, Ahlqvist-Rastad J, Andersson M, Arnheim-Dahlström L, Bergman P, Granath F, Adori C, Hökfelt T, KĂĽhlmann-Berenzon S, Liljeström P, Maeurer M, Olsson T, Ă–rtqvist Ă…, Partinen M, Salmonson T, Zethelius B (2015) A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009–2010 Pandemrix vaccination programme in Sweden. J Intern Med 278(4):335–353

    Article  CAS  Google Scholar 

  • Gadroen K, Straus SMJM, Pacurariu A, Weibel D, Kurz X, Sturkenboom MCJM (2016) Patterns of spontaneous reports on narcolepsy following administration of pandemic influenza vaccine; a case series of individual case safety reports in Eudravigilance. Vaccine 34(41):4892–4897

    Article  Google Scholar 

  • Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC (2008) Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA 300(16):1887–1896

    Article  CAS  Google Scholar 

  • Goedecke T, Morales D, Pacurariu A, Kurz X (2018) Measuring the impact of medicines regulatory interventions: systematic review and methodological considerations. Br J Clin Pharmacol 84:419–433

    Article  Google Scholar 

  • Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, JovĂ© J, Gatta A, McCormick PA, Metselaar HJ, Monteiro E, Thorburn D, Bernal W, Zouboulis-Vafiadis I, de Vries C, Perez-Gutthann S, Sturkenboom M, BĂ©nichou J, Montastruc JL, Horsmans Y, Salvo F, Hamoud F, Micon S, Droz-Perroteau C, Blin P, Moore N (2013) Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study. Drug Saf 36(2):135–144

    Article  CAS  Google Scholar 

  • Herings RM, Urquhart J, Leufkens HG (1999) Venous thromboembolism among new users of different oral contraceptives. Lancet 354(9173):127–128

    Article  CAS  Google Scholar 

  • Hernandez JF, Mantel-Teeuwisse AK, van Thiel GJ, Belitser SV, Warmerdam J, de Valk V, Raaijmakers JA, Pieters T (2012) A 10-year analysis of the effects of media coverage of regulatory warnings on antidepressant use in the Netherlands and UK. PLoS One 7(9):e45515. https://doi.org/10.1371/journal.pone.0045515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jandoc R, Burden AM, Mamdani M, LĂ©vesque LE, Cadarette SM (2015) Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations. J Clin Epidemiol 68(8):950–956

    Article  Google Scholar 

  • Klungel OH, Kurz X, de Groot MC, Schlienger RG, Tcherny-Lessenot S, Grimaldi L, Ibáñez L, Groenwold RH, Reynolds RF (2016) Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project. Pharmacoepidemiol Drug Saf 25(Suppl 1):156–165

    Article  Google Scholar 

  • Komen J, Forslund T, Hjemdahl P, Andersen M, Wettermark B (2017) Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis. Br J Clin Pharmacol 83(3):642–652

    Article  CAS  Google Scholar 

  • Kurz X, Perez-Gutthann S (2018) ENCePP steering group strengthening standards, transparency, and collaboration to support medicine evaluation: ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Pharmacoepidemiol Drug Saf 27(3):245–252

    Article  Google Scholar 

  • Lapeyre-Mestre M, Sapède C, Moore N et al (2013) Pharmacoepidemiology studies: what levels of evidence and how can they be reached? Therapie 68(4):241–252

    Article  Google Scholar 

  • Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, PottegĂĄrd A (2018) Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark. J Am Acad Dermatol 78(4):673–681

    Article  CAS  Google Scholar 

  • Piening S, Haaijer-Ruskamp FM, de Vries JTN, van der Elst ME, de Graeff PA, Straus SMJM, Mol PGM (2012) Impact of safety-related regulatory action on clinical practice: a systematic review. Drug Saf 35:373–385

    Article  Google Scholar 

  • Pitts PJ, Louet HL, Moride Y, Conti RM (2016) 21st century pharmacovigilance: efforts, roles, and responsibilities. Lancet Oncol 17(11):e486–e492

    Article  Google Scholar 

  • Potts J, Genov G, Segec A, Raine J, Straus S, Arlett P (2019) Improving the safety of medicines in the EU: from signals to action. Clin Pharmacol Ther. https://doi.org/10.1002/cpt.1678. [Epub ahead of print]

  • Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang HY, Coplan P, Li H, BRACE Special Interest Group (2015) Benefit-risk assessment, communication, and evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist. Pharmacoepidemiol Drug Saf 24(12):1233–1240

    Article  Google Scholar 

  • Rassen JA, Shelat AA, Franklin JM, Glynn RJ, Solomon DH, Schneeweiss S (2013) Matching by propensity score in cohort studies with three treatment groups. Epidemiology 24(3):401–409

    Article  Google Scholar 

  • Santa-Ana-Tellez Y, Mantel-Teeuwisse AK, Dreser A, Leufkens HG, Wirtz VJ (2013) Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico. PLoS One 8(10):e75550. https://doi.org/10.1371/journal.pone.0075550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Segec A, Keller-Stanislawski B, Vermeer NS, Macchiarulo C, Straus SM, Hidalgo-Simon A, De Bruin ML (2015) Strategy in regulatory decision-making for management of progressive multifocal Leukoencephalopathy. Clin Pharmacol Ther 98(5):502–505

    Article  CAS  Google Scholar 

  • Sheiner LB (1997) Learning versus confirming in clinical drug development. Clin Pharmacol Ther 61(3):275–291

    Article  CAS  Google Scholar 

  • Skovlund E, Leufkens HGM, Smyth JF (2018) The use of real-world data in cancer drug development. Eur J Cancer 101:69–76

    Article  CAS  Google Scholar 

  • Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS (1992) The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 326(8):501–506

    Article  CAS  Google Scholar 

  • Sultana J, Fontana A, Giorgianni F, Tillati S, Cricelli C, Pasqua A, Patorno E, Ballard C, Sturkenboom M, Trifirò G (2019) Measuring the effectiveness of safety warnings on the risk of stroke in older antipsychotic users: a Nationwide cohort study in two large electronic medical records databases in the United Kingdom and Italy. Drug Saf. https://doi.org/10.1007/s40264-019-00860-z. [Epub ahead of print]

  • van Dalem J, Brouwers MC, Stehouwer CD, Krings A, Leufkens HG, Driessen JH, de Vries F, Burden AM (2016) Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study. BMJ 354:i3625

    Article  Google Scholar 

  • Van der Kroef C (1991) Triazolam. Lancet 338(8758):56

    Article  Google Scholar 

  • Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    Article  Google Scholar 

  • Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendaal FR (2001) Oral contraceptives and the risk of venous thrombosis. N Engl J Med 344(20):1527–1535

    Article  CAS  Google Scholar 

  • Vermeer NS, Ebbers HC, Straus SM, Leufkens HG, Egberts TC, De Bruin ML (2016) The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study. Pharmacoepidemiol Drug Saf 25(3):297–306

    Article  Google Scholar 

  • Weatherburn CJ, Guthrie B, Dreischulte T, Morales DR (2019) Impact of medicines regulatory risk communications in the United Kingdom on prescribing and clinical outcomes: systematic review, time series analysis and meta-analysis. Br J Clin Pharmacol. https://doi.org/10.1111/bcp.14104. [Epub ahead of print]

  • Wettermark B (2013) The intriguing future of pharmacoepidemiology. Eur J Clin Pharmacol 69(Suppl 1):43–51

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands

    Hubert G. Leufkens

Authors
  1. Hubert G. Leufkens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hubert G. Leufkens .

Editor information

Editors and Affiliations

  1. European Medicines Agency (EMA), Amsterdam, Noord-Holland, The Netherlands

    Priya Bahri

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Leufkens, H.G. (2020). Pharmacoepidemiology. In: Bahri, P. (eds) Communicating about Risks and Safe Use of Medicines. Adis, Singapore. https://doi.org/10.1007/978-981-15-3013-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-3013-5_14

  • Published:

  • Publisher Name: Adis, Singapore

  • Print ISBN: 978-981-15-3012-8

  • Online ISBN: 978-981-15-3013-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation